Cite
HARVARD Citation
Yetmar, Z. et al. (2022). Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild‐to‐moderate coronavirus disease 2019 during the Omicron epoch. Transplant infectious disease. 24 (4), p. n/a. [Online].